Our transcriptome data suggest that the absence of B cells enhances Tregs/immune checkpoints and inflammation in tumors and these changes suppress anti-PDL1-induced anti-tumor immune response and reduce mouse survival. The gene discussed is CD274; the disease is neoplasm.